Free CME for Physicians
The CME & Contact Hours You Need Today for Physician License Renewal
We are proud to sponsor this educational initiative, dedicated to providing Physician CME, CEUs & Contact Hours required by many state boards for Physician license renewal. Check back often for updates, including new free Physician CME courses offering free AMA Pra CAT 1 CME that are posted frequently. Through extensive content review, our staff approves Physician CME courses that are timely and approved for AMA Credit.**
To check Physician CME requirements by STATE CLICK HERE!
|
|
1.25 Free AMA CME Updates in Melanoma 2015: Entering a New Therapeutic Era- Evaluate the clinical safety and efficacy profiles of new and emerging therapies for the treatment of melanoma, including immunotherapy, targeted therapy, and intralesional therapy. Assess the clinical utility of available and emerging therapies for the treatment of melanoma. Evaluate strategies for combining and sequencing targeted and immunotherapeutic agents for the treatment of melanoma.
(Expires 8/1/16) |
& be notified new FREE CME has posted!
Featured Free CME of the Month
NEW! 1.0 Free AMA CME New Trends in Hemodynamics: Dynamic Assessments- Describe the risks of over- and under-resuscitation. Describe the present methods of fluid assessment. Describe the present methods of hemodynamic monitoring. Given patient cases, reason your approach to fluid management under various clinical circumstances.
4.75 Free AMA CME Advanced Practice Modules in Schizophrenia- Integrate uncommon or conflicting findings in making a complete differential diagnosis of schizophrenia. Differentiate appropriate antipsychotic therapies and long-term management strategies according to different stages of schizophrenia, accounting for factors including cognitive function, quality of life, adherence, and side effects. Assess the probability of relapses based on patient history, behavioral patterns, symptoms, and associated precipitating events. Evaluate the quality and strength of evidence from clinical trials on antipsychotic therapies for schizophrenia. Apply recently published efficacy and safety evidence on antipsychotic agents in making treatment decisions for patients with schizophrenia. Develop individualized treatment plans based on patient comorbidities and susceptibility to side effects for complex schizophrenia cases. Incorporate key findings from studies conducted to identify factors that predict better adherence to antipsychotic medications.
1.0 Free AMA CME OfficePerspectives: Understanding Parkinson’s Disease: Early Diagnosis, Treatment Options, and Complications- Incorporate strategies for an earlier, and more accurate diagnosis of Parkinson’s disease. Assess current and emerging therapeutic interventions used to manage motor fluctuations and dyskinesias in Parkinson’s disease. Evaluate the data for therapies used for the treatment of non-motor symptoms associated with Parkinson’s disease. Recognize the importance of patient education and counseling for patients with Parkinson’s disease.
1.0 Free AMA CME Where Are We with Suicide Prevention? Complete and document a suicide risk assessment for all patients with a mental health disorder.
1.0 Free AMA CME OfficePerspectives: Understanding Parkinson’s Disease: Early Diagnosis, Treatment Options, and Complications- Incorporate strategies for an earlier, and more accurate diagnosis of Parkinson’s disease. Assess current and emerging therapeutic interventions used to manage motor fluctuations and dyskinesias in Parkinson’s disease. Evaluate the data for therapies used for the treatment of non-motor symptoms associated with Parkinson’s disease. Recognize the importance of patient education and counseling for patients with Parkinson’s disease.
1.0 Free AMA CME Where Are We with Suicide Prevention? Complete and document a suicide risk assessment for all patients with a mental health disorder.
|
1.5 Free CME Identifying the Pathway to Successful Patient Care: Practical Implementation of Incretin-Based Therapies in Type 2 Diabetes– Evaluate the benefits and risks of intensive glycemic control in T2D. Explain the rationale for incretin-based therapies. Compare and contrast the mechanism of action and modalities between GLP-1 receptor agonists and DPP-4 inhibitors. Recognize and differentiate between the administration routes, efficacy, and potential nonglycemic benefits associated with GLP-1 receptor agonists and DPP-4 inhibitors. Outline the safety considerations for GLP-1 receptor agonists and DPP-4 inhibitors. Discuss the need for patient education regarding the use of GLP-1 receptor agonists and DPP-4 inhibitors.
|
|
1.0 Free AMA CME Hypertension and Chronic Kidney Disease: A Public Health Priority– Describe the prevalence of hypertension and kidney disease in Philadelphia including the current level of health disparities. Review efforts of the Philadelphia Department of Public Health to create a healthier city, specifically related to factors that contribute to hypertension. Discuss three reasons why high blood pressure is important as a contributing factor in kidney disease. Review the benefits of blood pressure reduction in kidney disease. Provide the evidence for what the blood pressure goal should be in patients with kidney disease. (+ RN)
0.75 Free AMA CME Applying Science to the Improved Diagnosis and Treatment of Patients with Alzheimer’s Disease- Describe the most current understanding of the pathophysiology of AD, including risk factors. Utilize current criteria for the diagnosis of mild cognitive impairment (MCI) and AD. Discuss the differential diagnosis of MCI and dementia based on individual patients. List the common biomarkers for diagnosing AD. Review criteria for the staging of AD dementia. Discuss current and emerging treatment options for AD. Implement best practices for managing comorbid conditions, and managing treatment expectations.
0.75 Free AMA CME Applying Science to the Improved Diagnosis and Treatment of Patients with Alzheimer’s Disease- Describe the most current understanding of the pathophysiology of AD, including risk factors. Utilize current criteria for the diagnosis of mild cognitive impairment (MCI) and AD. Discuss the differential diagnosis of MCI and dementia based on individual patients. List the common biomarkers for diagnosing AD. Review criteria for the staging of AD dementia. Discuss current and emerging treatment options for AD. Implement best practices for managing comorbid conditions, and managing treatment expectations.
|
|
1.0 Free AMA CME Call to Arms: Overcoming Barriers to Adolescent Vaccination in Primary Care- Describe routine recommendations for vaccination of adolescents based on the current Advisory Committee on Immunization Practices (ACIP) guidelines. Identify adolescents who are at increased risk for vaccine-preventable diseases and thus should be vaccinated. Describe the different vaccines licensed in the United States for adolescents. Provide solutions to patients and physicians to improve vaccination rates. |
1.0 Free AMA CME Selecting Evidence-Based Pharmacologic Therapy and Designing Multimodal Treatment Plans for Migraine and Headache- Establish differential diagnosis for chronic migraine in accordance with the ICHD-III beta criteria and evaluate risk for transitioning from episodic to chronic migraineEmploy validated clinical tools to evaluate migraine-related disability, set treatment goals, and monitor treatment response, including patient adherence to therapy.
0.75 Free AMA CME Infant Formula Stretching: A Pediatrician’s Guide to Addressing the Critical Needs of Food-Insecure Families- Utilize appropriate screening tools to identify families of infants at risk of formula-stretching practices that may result from food-insecurities. Discuss enforced regulations and clinical evidence that support the safety, tolerability, and nutritional comparability of all FDA approved infant formulas. Translate clinical evidence of infant formula switching to effective patient education, addressing family concerns of nutritional value, safety, tolerability, and affordability. (+ RPH)
0.75 Free AMA CME Infant Formula Stretching: A Pediatrician’s Guide to Addressing the Critical Needs of Food-Insecure Families- Utilize appropriate screening tools to identify families of infants at risk of formula-stretching practices that may result from food-insecurities. Discuss enforced regulations and clinical evidence that support the safety, tolerability, and nutritional comparability of all FDA approved infant formulas. Translate clinical evidence of infant formula switching to effective patient education, addressing family concerns of nutritional value, safety, tolerability, and affordability. (+ RPH)
